Jane Street’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-163
Closed -$13K 10977
2021
Q2
$13K Sell
163
-74
-31% -$4.51K ﹤0.01% 9667
2021
Q1
$16K Buy
+237
New +$18.5K ﹤0.01% 8998

Other funds holding DMK

Jane Street's DMK Position: Q1 2023 in Review

Jane Street sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2023, closing a stake of 1,383 shares — an estimated $16.4K sold.

Jane Street first reported a position in DMK in Q1 2014 and held it in 12 quarters. The position peaked at $103K in Q1 2014. 47 funds tracked by Wall St. Rank hold DMK as of Q1 2023.

  • Jane Street reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 1,383 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2023, an estimated $16.4K.
  • Jane Street first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 12 quarters.
  • Jane Street's DMK Pharmaceuticals Corporation Common Stock position peaked at $103K in Q1 2014.
  • 47 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.